gastrointestinal submucosal lesions
Conditions
Interventions
None listed
Sponsors
Fukushima Medical University Aizu Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.A patient having SMT less than 15mm. 2.When the whole lesion can be observed with the forward-viewing echoendoscope, and a puncture route is secured, and can puncture it safely. 3.When EUS-FNA brings the information that is important to the treatment choice of the patient. 4.After having received enough explanation about inspection,the patient that understood enough, and a document agreement was provided. 5.Performance status does not have the limit in particular.
Exclusion criteria
Exclusion criteria: 1.Blood disorder (hemoglobin <7.0 g/dL or platelet <100000/uL) 2.Renal disease (blood BUN> 25 mg/dL or blood creatinine> 2.0 mg/dL) 3.Liver disease (Child Pugh score> 6) 4.Extension of the solidification time(for warfarin potassium internal use or cirrhosis,Under 70 years old PT-INR> 3.0, 70 years old or more PT-INR>2.6) 5.Case to have serious complications to other organs.More than the three of the ASA classification(the dialysis patient is excluded) 6.Case not to be provided of Informed consent 7.In addition, the patient who judged the examination medical attendant to be inappropriate as a subject
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| rate of sampling, accuracy, and complication | — |
Secondary
| Measure | Time frame |
|---|---|
| Kind of used device | — |
Countries
Japan
Contacts
Public ContactAkane Yamabe
Fukushima Medical University Aizu Medical Center Gastroenterology
Outcome results
None listed